NMPA Approval

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Approval Number

国药准字H37020442

Company北京京丰制药（山东）有限公司

Registration Date

March 20, 2025

Drug Information

Generic Name

联磺甲氧苄啶片

Dosage Form

片剂

Strength

磺胺甲噁唑0.2g,磺胺嘧啶0.2g,甲氧苄啶80mg

Drug Type

化学药品

Registration Date

March 20, 2025

Company Information

Applicant Company

Company Name北京京丰制药（山东）有限公司

Company Address

山东省淄博市博山区九州路9号

Manufacturing Company

Company Name北京京丰制药（山东）有限公司

Company Address

山东省淄博市博山区九州路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

联磺甲氧苄啶片 - NMPA 批准文号 | MedPath